INTRODUCTION
============

The widespread use of Highly Active Antiretroviral Therapy (HAART) has promoted a sustained reduction in both morbidity and mortality associated with HIV-1[@B20] ^,^ [@B33]. Although the curve of the HIV epidemic has been showing signs of flattening around the world, HIV infection remains almost invariably fatal if the individuals are not treated with HAART[@B06] ^,^ [@B33] ^,^ [@B38].

Despite the increases in the availability of HAART, other challenges related to the management of patients with HIV are just beginning to surface. For example, HAART itself can cause a variety of adverse effects such as the lipoatrophy/lipohypertrophy syndrome[@B03] ^,^ [@B04] ^,^ [@B08] ^,^ [@B09]. Such an occurrence may contribute to a decrease in adherence to antiretroviral therapy, adding to the difficulties inherent to prolonged treatment with combinations of drugs which characterize HAART[@B14]. Moreover, both the changes in the composition and distribution of body fat may negatively affect self-image, thus interfering with treatment adherence and contributing to possible therapeutic failure[@B02] ^,^ [@B09].

Although there is no consensus on the prevention or treatment of the lipoatrophy/lipohypertrophy syndrome, the World Health Organization has indicated that nutrition should be a part of all programs for control and treatment of HIV/AIDS, since diet and adequate nutritional status can improve adherence and effectiveness of treating patients on HAART[@B10] ^,^ [@B36]. The identification of early morphological changes for these patients through the assessment and diagnosis of their nutritional status can help to establish effective interventions for the treatment of metabolic and morphological reactions[@B14] ^,^ [@B31]. Identification and appropriate treatment for these conditions can both improve patients\' long-term care and help provide a better outlook for their quality of life[@B02] ^,^ [@B19] ^,^ [@B21].

According to the American Dietetic Association, anthropometry has been widely used to assess the health and nutritional status of individuals, communities or populations, not only due to its simplicity and low cost, but also because it can provide an approximation of body composition and distribution of body fat[@B01] ^,^ [@B15] ^,^ [@B18]. The aim of this study was to assess the prevalence of self-reported lipoatrophy/lipohypertrophy and nutritional status by anthropometric measurements in patients with HIV/AIDS in a cohort of outpatient HIV-infected persons in São Paulo, Brazil.

MATERIAL AND METHODS
====================

This observational study was based on data collected between September 2006 and July 2008 from a referral center for the treatment of HIV infection in São Paulo, Brazil, in the Secondary Immunodeficiencies Outpatient Department of Dermatology, Hospital das Clínicas, Faculty of Medicine, University of São Paulo (ADEE 3002-HCFMUSP). The study was approved by the Research Ethics Committee of the University of São Paulo Medical School (Research Protocol No. 0221/07).

This open cohort consists of 320 HIV-1-positive patients who have been followed since 1989. The sample consisted of 227 subjects (71% of the cohort) divided into three groups:

Group 1 = 92 HIV-1-positive patients on HAART and with self-reported lipoatrophy/lipohypertrophy syndrome (LLS); Group 2 = 70 HIV-1-positive patients on HAART without self-reported LLS; Group 3 = 65 HIV-1-positive patients without HAART.

The characterization of groups in terms of self-reported lipodystrophy was conducted through a questionnaire to identify socio-demographic, clinical characteristics, as well as a specific question for the patient to determine if he/she had observed bodily changes consistent with LLS after the initiation of HAART. Study inclusion criteria were HIV infection, willingness to sign the consent form and no constraint for the test performance of bioimpedance (BIA). Exclusion criteria were pregnancy, known cardiovascular disease or previous heart surgery and refusal to sign the consent form. All the patients were interviewed by the first Author using an adapted questionnaire to identify morphological body modifications after the initiation of HAART.

Anthropometric methods, which included body mass index (BMI), waist/hip ratio (WHR), waist circumference (WC) as well as an estimate of body fat percentage (BF%), were used to evaluate the nutritional status of patients and possible changes in the deposition of fat in specific areas of the body. In addition, bioelectrical impedance (BIA) was also performed[@B08] ^,^ [@B11] ^,^ [@B13].

BMI was calculated as the ratio of the current weight (kg) by height (m) squared[@B16] ^,^ [@B17] ^,^ [@B39]. BF% was calculated as the sum of skinfolds of upper and lower limbs. The nutritional status was classified according to WHO recommendations for adults[@B37].

The assumed value of triceps skinfold (TSF), (mm[@B02]), was the average of three measurements and percentages[@B16], by sex and age. The nutritional status classification was determined according to the recommendations of BLACKBURN and THORNTON[@B05]. Skinfold measurements were performed on the triceps, biceps, subscapular, abdominal, iliac, thigh and calf. These were obtained with the aid of the caliper Cescorf® (Cescorf, Porto Alegre, Brazil) and rounded to the nearest 0.5 mm and made in duplicate for each type of measurement[@B16]. Classification of % BF was based on recommendations made by GALLAGHER *et al.* by means of prediction equations[@B17].

The percentage of body fat (% BF) was determined both as above described and by electrical impedance analysis (BIA) (Systems Inc. 101Q, RJL Systems, Clinton Township, MI). For examination of the BIA, the measurements were made on the right side of the body and patients were asked about restrictions for the performance of these tests[@B12]. Measurements were performed according to the instructions in the user manual from CompCorp. The values of resistance and inductance were interpreted by software from Vcorp[@B11]. Using the IDF classification, WC cutoffs were used for the diagnosis of metabolic syndrome[@B25] ^,^ [@B26]. All measurements were done by one of the Authors (LS).

In addition to anthropometric data, socio-demographic characteristics were recorded as categorical and continuous variables: gender, age, education, social interaction, marital status, housing conditions, income and employment status, total duration of HAART, CD4 T-cell count, length of time from the first positive HIV test, the current HIV viral load and the presence of self-reported lipoatrophy/lipohypertrophy.

Statistical analyses were performed using the software Minitab® 15m to verify that changes in nutritional status and body fat distribution were related to gender, use of HAART and presence of lipoatrophy/lipohypertrophy[@B30]. These were performed by descriptive analysis. To evaluate the association between categorical variables, the chi-square test was used. For the relationship between quantitative and categorical variables with normal distribution, the Student t-test (for two variables) was used. An association was made between variables of the study (anthropometrics and body fat distribution) according to defined groups (G1, G2, G3) and analyzed by ANOVA (used for three variables), with a confidence level of 95% and 5% significance according to the Tukey test for comparison.

RESULTS
=======

The average age of the 227 study subjects was 42.5 years with 75 (33%) being female. Average length of education was 11 years and most subjects shared a residence with three or more persons. The majority of men were single individuals. Over half of the patients own their own homes with proper sanitation and the per capita income was one to five times the minimum wage. There was no statistically significant difference by gender for these variables. Self-reported prevalence of the LLS was 33% among women and 59% among men ([Table 1](#t01){ref-type="table"}).

###### Socio-demographic characteristics of the 227 HIV-1-infected individuals by gender

  Variable                         Males (152)   Females (75)   *p* value
  -------------------------------- ------------- -------------- -----------
  **Age (Mean ± SD), years**       43 ± 8        42 ± 9         NS
  **Years of schooling**                                        NS
      Unknown                      13 (8.55)     5 (6.66)        
      None                         1 (0.65)      1 (1.33)        
      ≤ 8 years                    41 (26.97)    22 (29.33)      
      9-11 years                   62 (40.78)    39 (52)         
      \>11 years                   38 (25)       7 (9.33)        
  **Home sharing**                                              NS
      Unknown                      12 (7.89)     5 (6.66)        
      No                           34 (22.36)    4 (5.33)        
      With 2 persons               31 (20.39)    13 (17.33)      
      With more than 2 persons     74 (48.68)    52 (69.33)      
  **Marital status**                                            NS
      No answer                    15 (9.86)     6 (8)           
      Single                       83 (54.60)    20 (26.66)      
      Married                      24 (15.78)    20 (26.66)      
      Divorced                     9 (5.92)      17 (22.66)      
  **Home ownership**                                            NS
      No answer                    15 (9.86)     8 (10.66)       
      Owner                        82 (53.94)    42 (56)         
      Tenant                       44 (28.94)    20 (26.66)      
      Other                        11 (7.23)     4 (5.33)        
  **Employment condition**                                      NS
      No answer                    10 (6.57)     6 (8)           
      Employed                     103 (67.76)   42 (56)         
      Unemployed                   39 (25.65)    27 (36)         
  **Income (minimum wage)**                                     NS
      None                         10 (6.57)     12 (16)         
      \< 1                         11 (7.23)     13 (17.33)      
      1-5                          97 (63.81)    36 (48)         
      6-10                         16 (10.52)    6 (8)           
      \> 10                        4 (2.63)      \-              
      No answer                    13 (8.55)     7 (9.33)        
  **Self reported body changes**   59 (38.81%)   33 (44%)        

NS: Not statistically significant *when p* value \> 0.05; Income: 1 minimum wage = \~ U\$300.00.

In [Table 2](#t02){ref-type="table"}, it is noted that this group had, on average, longer use of HAART, a higher T CD4 cell nadir, and more years of clinical follow-up compared with those without self-reported lipodystrophy and those not taking HAART. Analysis of triceps skinfold (TSF) found a depletion of fat mass in groups undergoing treatment with HAART and this result was statistically significant when compared to the group without HAART (for men *p* = 0.001, for women *p* = 0.007). A similar result was determined in the analysis of skin folds of the upper and lower limbs, where groups using HAART had greater loss of fat tissue which was statistically significant compared to Group 3 (*p* = 0.001) (*p* = 0.003). In the assessment of nutritional status by BMI, the majority of men were eutrophic. However this result was not statistically significant between groups (*p* = 0.72). Similarly, measurement of the sum of skinfolds revealed excess body fat tissue in all groups. Men on HAART and with self-reported lipodystrophy were identified by WHR measurements as having statistically significant higher risk for cardiovascular diseases when compared to those without LLS (*p* = 0.0001). However, when the comparison refers to CA ≥ 90 cm no significant difference was found between men in the three groups.

###### Cardiovascular risk according to sex, anthropometric variables and self-reported groups of lipoatrophy/lipohypertrophy syndrome (LLS)

  Variables                                                                    Males            Females                                                                                             
  ---------------------------------------------------------------------------- ---------------- ---------------- -------------------- ------- ---------------- ---------------- ------------------- -------
  **Subjects**                                                                 59               52               41                           33               18               24                   
  **Years under HAART**                                                        7 ± 4            5 ± 4            \-                   0.02    7 ± 4            4 ± 5                                0.01
  **Nadir TCD4 cells (cels/mm^3^)**                                            542 (335-732)    359 (187-503)    431 (287-628)        0.01    427 (310-607)    342 (267-468)    474 (396-804)       0.04
  **Median (Q1-Q3)**                                                                                                                                                                                 
  **Time of HIV infection since diagnosis**                                    9 ± 5            5 ± 4            2 ± 3                0.001   9 ± 5            5 ± 5            5 ± 6               0.003
  **HIV viral load (copies/Ml)**                                               400 (400-1053)   400 (400-3309)   15000 (1993-65675)   0.000   436 (400-6178)   400 (138-1576)   4410 (1632-14350)   0.009
  **TSF**                                                                                                                             0.001                                                         0.007
      Depletion                                                                50 (84.74%)      42 (80.76%)      20 (48.78%)                  26 (78.78%)      15 (83.33%)      12 (50%)             
      Eutrophic                                                                4 (6.77%)        6 (11.53%)       3 (7.31%)                    6 (18.18%)       3 (16.66%)       4 (16.66%)           
      Excess                                                                   5 (8.47%)        4 (7.69%)        17 (41.46%)                  1 (3.03%)        \-               8 (33.33%)           
  **% folds members**                                                          32 ± 7           35 ± 9           38 ± 7               0.001   39 ± 9           45 ± 8           46 ± 7              0.003
  **Mean ±SD**                                                                                                                                                                                       
  **BMI**                                                                                                                             0.72                                                          0.05
      Depletion                                                                \-                                \-                                                                                  
      Eutrophic                                                                32 (54.23%)      28 (53.84%)      20 (48.78%)                  \-               1 (5.55%)        \-                   
      Excess                                                                   27 (45.76%)      24 (46.15%)      20 (48.78%)                  12 (36.36%)      13 (72.22%)      12 (50%)             
  **% fat by Durnin**                                                                                                                 0.03                                                          0.014
      Depletion                                                                \-                                1 (2.43%)                    \-                                \-                   
      Eutrophic                                                                4 (6.77%)        16 (30.76%)      6 (11.53%)                   \-                                1 (4.16%)            
      Excess                                                                   53 (89.83%)      33 (63.46%)      31 (75.60%)                  33 (100%)        18 (100%)        23 (95.83%)          
  **% fat by BIA**                                                                                                                    0.13                                                          0.19
      Depletion                                                                4 (6.77%)        \-               3 (7.31%)                    \-               \-               \-                   
      Eutrophic                                                                22 (37.28%)      26 (50%)         9 (21.95%)                   4 (12.12%)       5 (27.77%)       2(8.33%)             
      Excess                                                                   33 (55.93%)      25 (48.07%)      27 (65.85%)                                                                         
  **Cardiovascular risk assessed by waist/hip ratio**                                                                                 0.001                                                         0.005
      Low and Intermediate                                                     27 (45.76%)      32 (61.53%)      28 (68.29%)                  2 (6.06%)        4 (22.22%)       5 (20.83%)           
      High and very high                                                       32 (54.23%)      20 (38.46%)      12 (29.26%)                  31 (93.93%)      14 (77.77%)      19 (79.16%)          
  **Cardiovascular risk assessed by waist circumference according to WHO**                                                            0.63                                                          0.01
      Low and intermediate                                                     52 (88.13%)      49 (94.23%)      35 (85.36%)                  11 (33.33%)      11 (61.11)       13 (54.16%)          
      High                                                                     5 (8.47%)        3 (5.76%)        5 (12.19%)                   22 (66.66%)      7 (38.88%)       5 (20.83%)           
  **Cardiovascular risk assessed by waist circumference - according to IDF**                                                          0.63                                                          0.01
      Men ≥ 90 and women ≥ 80                                                  30 (50.84%)      24 (46.15%)      18 (43.90%)                  30 (90.90%)      10 (55.55%)      19 (79.16%)          

SD = Standard Deviation. Group 1 = Self-reported lipoatrophy/lipohypertrophy and HAART. Group 2 = HAART and no lipoatrophy/lipohypertrophy and Group 3 = Not on HAART.For relationships between categorical and quantitative variables with normal distribution the t student's test was used (for two variables). The association between the study variables (anthropometry and body fat distribution) was performed according to defined groups (G1, G2 and G3) and analyzed by ANOVA (used for 3 variables), with a confidence level of 95% and significance of 5%, according to the comparison test of Tukey.

For women under HAART and with lipodystrophy, the measurements for WHR and CA showed a higher risk for cardiovascular diseases (*p* = 0.005 and *p* = 0.01, respectively).

DISCUSSION
==========

The strengthening of social support, adherence to treatment and the establishment of life goals are important factors in the quality of life for those living with HIV[@B39]. The socio-demographic characteristics of this study reflect the epidemiological trends of HIV in Brazil. With a ratio of two men to one woman, an increasing number of women were observed, mainly due to heterosexual transmission of HIV being observed more recently[@B06]. Most patients in this study have, on average, some level of school education, and most are employed with reasonably stable incomes and good social status, unlike other groups of patients with HIV in Brazil who predominantly have a low level of education and poor social conditions.

Overall, body changes have been reported in 20-80% of patients on HAART, consisting primarily of Caucasian males, which roughly agrees with the results of this study[@B07] ^,^ [@B22]. When subcutaneous fat of the upper and lower limbs was estimated by TSF, a depletion of fat mass was found in groups undergoing treatment by HAART. These results support the hypothesis that morphological changes associated with lipoatrophy of the upper and lower limbs are common among HIV-infected individuals undergoing HAART. There are no standardized criteria for the diagnosis of LLS and such changes are clinically evident approximately six to 24 months after HAART[@B28] ^,^ [@B29] ^,^ [@B33].

To identify changes in the distribution of body fat, monitoring of skinfolds has been recommended[@B05] ^,^ [@B23] ^,^ [@B24]. According to HEYWARD & STOLARCKZYK, these anthropometric measurements have been used in studies focusing on HIV/AIDS in developed countries, yet currently there is little published data using the sum of skinfolds for the distribution of fat per body segment in adults with HIV infection[@B10] ^,^ [@B26] ^,^ [@B33].

A study by SANCHES[@B36] also found that 57% of their sample showed accumulation of abdominal fat, 55% had decreased peripheral fat with loss of subcutaneous tissue in the arms, legs and buttocks, and 33% stated that if they knew their physical appearance would acquire such a form, they would have opted not to begin treatment despite being aware of the risks to their health.

The cardiovascular risk associated with obesity has been defined by observational evidence, especially in cohort and case-control studies such as the Nurses\' Health Study, which showed a relative risk of death of 1.6 to 2.2 associated with a BMI between 27 and 32, compared to the group with BMI \< 19. The NHANES Study - National Health and Nutrition Examination Survey- reported a 1.5 relative risk for CVD later in life for women with BMI \> 29, compared to a reference population with BMI \< 21[@B40].

Although BMI is employed in most population studies because of ease of use, it does not provide enough data to accurately assess body composition. Thus, there is an increased interest in measurements that best describe the amount of body fat and its relationship with obesity. BMI in itself provides only an incomplete picture of cardiovascular risk since it does not identify individuals with abdominal obesity[@B18] ^,^ [@B32] ^,^ [@B34].

This study found a high prevalence of increased body fat (BF) and of individuals described as overweight when assessed by BMI and by their percentage of BF, particularly women undergoing HAART and with self-reported lipodystrophy. Additionally for this group, high values of WHR and of Abdominal Circumference point to a high cardiovascular risk.

Among 223 HIV-infected individuals aged 20-59 from the city of São Paulo, the prevalence of central obesity was 45.7%, with women having a higher prevalence of abdominal obesity and overweight status when compared to men, coinciding with the results of this study[@B07] ^,^ [@B27]. The author also cites previous studies with patients treated using protease inhibitors showing that the accumulation of fat is often higher among women[@B12] ^,^ [@B15]. Also, the development of male body patterns has been reported in most women with LLS[@B15] ^,^ [@B20]. Such results agree with the findings of the present research.

Despite the limitations of this study, such as sample size, study design and cohort effect, the results indicate that other anthropometric measurements in addition to BMI are important for assessing the nutritional status of patients with LLS undergoing HAART. Insights regarding the relative value of using multiple measurements to assess the nutritional status of HIV-infected individuals were obtained. Thus, the analysis of skinfold thickness, which should be a practice adopted by all multidisciplinary teams, can help identify individuals at high risk for lipoatrophy/lipohypertrophy syndrome and for concurrent metabolic alterations.

CONCLUSIONS
===========

1.  \- Anthropometric assessment through skinfold measurements proved to be a good method for determining loss of fatty tissue in the upper and lower limbs, regardless of gender, in HIV-infected patients undergoing HAART.

2.  \- The BMI alone does not seem to be an adequate parameter for assessing the nutritional status of HIV-infected patients undergoing HAART and the lipoatrophy/lipohypertrophy syndrome. Other anthropometric measurements are needed to evaluate patients with the syndrome.

3.  \- There was a strong association between self-reported lipoatrophy/lipohypertrophy syndrome, HAART, body composition, and cardiovascular disease risk associated with abdominal obesity.

4.  \- These studies have identified the need to perform a variety of measurements to assess the nutritional status of persons living with HIV/AIDS in clinical practice.
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